Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders

Bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders

US Patent 10548892 · Granted Feb 4, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic compounds and methods for their use in treating Pitt Hopkins syndrome2025
Bicyclic compounds and methods for their use in treating autism2021
Bicyclic compounds and methods for their use in treating autism2021
Bicyclic compounds and methods for their use in treating autism2021
Neuroprotective bicyclic compounds and methods for their use in treating autism 2018
Neuroprotective bicyclic compounds and methods for their use in treating autism 2018
Neuroprotective bicyclic compounds and methods for their use in treating autism 2018
Neuroprotective bicyclic compounds and methods for their use in treating autism 2018
Treatment of fragile X syndrome using glycyl-L-2-methylprolyl-L-glutamate2017
Treatment of fragile X syndrome using glycyl-L-2-methylprolyl-L-glutamate2017
Treatment of rett syndrome using glycyl-L-2-methylprolyl-L-glutamic acid2015
Treatment of rett syndrome using glycyl-L-2-methylprolyl-L-glutamic acid2015